Hannah Brendan 4
4 · Quince Therapeutics, Inc. · Filed Aug 21, 2024
Insider Transaction Report
Form 4
Hannah Brendan
CBO, COO & CCO
Transactions
- Purchase
Common Stock
2024-08-21$0.63/sh+23,565$14,846→ 296,540 total - Purchase
Common Stock
2024-08-19$0.58/sh+2,155$1,250→ 259,771 total - Purchase
Common Stock
2024-08-20$0.61/sh+2,500$1,525→ 262,271 total - Purchase
Common Stock
2024-08-20$0.60/sh+3,424$2,054→ 265,695 total - Purchase
Common Stock
2024-08-21$0.61/sh+2,280$1,391→ 267,975 total - Purchase
Common Stock
2024-08-21$0.62/sh+5,000$3,100→ 272,975 total